Privia Health Group (NASDAQ:PRVA) Earns Overweight Rating from Stephens

Privia Health Group (NASDAQ:PRVA)‘s stock had its “overweight” rating reiterated by investment analysts at Stephens in a research note issued on Thursday,Benzinga reports. They presently have a $26.00 price objective on the stock. Stephens’ price target would indicate a potential upside of 30.26% from the stock’s previous close.

Several other equities analysts have also issued reports on PRVA. Macquarie started coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target on the stock. KeyCorp started coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price on the stock. Truist Financial increased their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Finally, Barclays increased their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $24.88.

Privia Health Group Stock Performance

PRVA stock opened at $19.96 on Thursday. The company has a market capitalization of $2.40 billion, a PE ratio of 199.62, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83. Privia Health Group has a one year low of $15.92 and a one year high of $23.78. The company’s 50 day moving average price is $20.71 and its two-hundred day moving average price is $19.30.

Institutional Investors Weigh In On Privia Health Group

Several hedge funds have recently bought and sold shares of PRVA. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group during the second quarter valued at approximately $26,000. GAMMA Investing LLC lifted its position in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares in the last quarter. Signaturefd LLC grew its stake in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after acquiring an additional 626 shares during the period. Quarry LP boosted its position in shares of Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after purchasing an additional 2,533 shares during the period. Finally, KBC Group NV boosted its holdings in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares during the period. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.